Sexual dysfunction and diabetes

International Journal of Clinical Practice

Volumn 58, Issue 4, 2004, Pages 358-362

  Jackson, Graham ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Diabetes; Sexual dysfunction; Treatment

Indexed keywords

AMLODIPINE; ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; APOMORPHINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; FELODIPINE; NICORANDIL; NITRATE; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; TADALAFIL; THIAZIDE DIURETIC AGENT; VARDENAFIL; WARFARIN;

AUTONOMIC NEUROPATHY; COMORBIDITY; COUNSELING; DIABETES MELLITUS; DISEASE MARKER; DRUG CONTRAINDICATION; DRUG HALF LIFE; DYSPEPSIA; ENDOTHELIUM INJURY; ERECTILE DYSFUNCTION; FATIGUE; FEMALE SEXUAL DYSFUNCTION; FIBROSIS; FLUSHING; HEADACHE; HEALTH PRACTITIONER; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOTENSION; LUBRICATION; MALE; MENTAL DISEASE; MYALGIA; ORGASM DISORDER; PAIN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIAPISM; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RHINITIS; SELF ESTEEM; SEXUAL AROUSAL; SEXUAL DYSFUNCTION; SIDE EFFECT; VASCULAR DISEASE;

ALPROSTADIL; APOMORPHINE; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; IMPOTENCE; LIFE STYLE; MALE; MEDICAL HISTORY TAKING; PENILE PROSTHESIS; PHOSPHODIESTERASE INHIBITORS; RISK FACTORS; SELF ADMINISTRATION; TESTOSTERONE; VACUUM;

EID: 2642532663     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2004.00180.x     Document Type: Review

References (16)

1. Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: results of the Massachusettes Male Ageing Study. J Urol 1994; 151: 54-61.
2. Solomon H, Man J, Wierzbicki AS et al. Erectile dysfunction: Cardiovascular risk and the role of the cardiologist. Int J Clin Pract 2003; 57: 96-9.
3. Marwick C. Survey says patients expect little physician help on Sex. JAMA 1999; 281: 2173-4.
4. Jackson G, Betteride J, Dean J et al. A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement - Update 2002. Int J Clin Pract 2002; 56: 663-71.
5. Rosen R, Riley A, Wagner G et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-30.
6. Fogari R, Zoppl A, Poletti L et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. J Hypertens 2002; 14: 27-31.
7. Lue TF. Erectile Dysfunction. N Engl J Med 2000; 342: 1802-13.
8. Boulton AJM, Selam J-L, Sweeney M, Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes. Diabetologia 2001; 44: 1296-301.
9. Giuliano F, Allard J. Apomorphine SL (Uprima): preclinical and clinical experience learned from the first central nervous system-acting ED drug. Int J Impot Res 2002; 14 (Suppl. 1): 553-6.
10. Ekman P, Sjogren L, Englund G, Perssin BE. Optimising the therapeutic approach of transurethral alprostadil. Br J Uro1 2000; 86: 68-74.
11. Montorsi F, Salonia A, Zanoni M et al. Current status of local penile therapy. Int J Impot Res 2002; 14 (Suppl. 1): S70-S81.
12. Porst H. The rationale for PGEI in erectile failure: a survey of world-wide experience. J Urol 1996; 155: 802-15.
13. Levine DA, Dimitriou RJ. Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am 2001; 2: 335-41.
14. Montague DK, Angermeir KW. Penile prosthetic implantation. Urol Clin North Am 2001; 28: 335-61.
15. Vermeulen A. Androgenic replacement therapy in the ageing male - a critical evaluation. J Clin Endocrinol Metab 2001; 86: 2380-90.
16. Basson R, Berman J, Burnett A et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000; 163: 888-93.